Strain SummaryB6.129S7-Trp53tm1Brd/+

Strain Name

 B6.129S7-Trp53tm1Brd/+

Strain Type(s)

 congenic  •  targeted mutation (knockout)

Strain Synonym(s)

 B6.129-Trp53tm1Brd/+  •  C57bl/6N12-Trp53 heterozygous (+/-)  •  C57BL/6TacfBR-[KO] p53 N5 heterozygous mice  •  C57Bl/6Tac-[KO]Trp53N5-T  •  heterozygous p53 knockout  •  p53+/-  •  p53(+/-)  •  p53+/-  •  p53-deficient  •  p53+/-  •  p53+/- Deficient

Description

 Heterozygous mice. The genetic background of these mice is congenic for C57BL/6NTac with some contribution from 129S7/SvEvBrd-Hprt+. Mice were purchased from Taconic.

Strain Genetics

 Trp53tm1Brd / Trp53+

Models

154 unique models displayed. A model is a set of tumors that share the same tumor name, organ(s) affected, and treatment type for a specific strain.
Frequency
Model Name Organ Affected Tumor Inducing Agent(s) Female Male Mixed Pop. Unspecified Additional Information Model Details
Adrenal gland - Cortex adenoma Adrenal gland - Cortex

0

0 - 0.2

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Adrenal gland - Cortex adenoma Adrenal gland - Cortex phenacetin

0

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Adrenal gland - Medulla pheochromocytoma Adrenal gland - Medulla

0

0.2 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Adrenal gland - Medulla pheochromocytoma Adrenal gland - Medulla Cyclosporin A

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Blood vessel hemangioma Liver

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangioma Heart

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangioma Liver d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangioma Heart d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangioma Liver urethane (ethyl carbamate)

0 - 65

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangioma Heart urethane (ethyl carbamate)

0 - 5

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Spleen

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Liver

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Abdominal cavity

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Liver urethane (ethyl carbamate)

0 - 40

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Spleen urethane (ethyl carbamate)

0 - 5

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Abdominal cavity urethane (ethyl carbamate)

0 - 5

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Abdominal cavity d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Spleen d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hemangiosarcoma Liver d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hyperplasia Liver urethane (ethyl carbamate)

10

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Blood vessel hyperplasia Heart urethane (ethyl carbamate)

5

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Bone osteosarcoma Bone - Jaw

0

1.9

References: Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11

Bone osteosarcoma Bone

0 - 6.7

0 - 0.5

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Bone osteosarcoma Bone benzene

0

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Bone osteosarcoma Bone Cyclosporin A

0 - 6.7

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

CNS - Brain - Astrocyte astrocytoma CNS - Brain - Astrocyte

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

CNS - Brain - Astrocyte astrocytoma CNS - Brain - Astrocyte Cyclosporin A

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

CNS - Meninges meningioma CNS - Meninges

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

CNS - Meninges meningioma CNS - Meninges phenacetin

0

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Connective tissue - Fibroblast fibrosarcoma Urinary bladder

0

0.9

References: Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11

Connective tissue - Fibroblast fibrosarcoma CNS - Meninges

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Connective tissue - Fibroblast fibrosarcoma CNS - Meninges cyclophosphamide (Cytoxan)

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Connective tissue - Fibroblast fibrosarcoma Subcutis

0 - 13.3

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Connective tissue - Fibroblast fibrosarcoma Subcutis Cyclosporin A

0 - 13.3

0 - 13.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Connective tissue - Fibroblast fibrosarcoma Subcutis chloroform

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Forestomach hyperplasia Forestomach d-limonene

85

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Forestomach hyperplasia Forestomach ampicillin

observed

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Kidney transitional cell hyperplasia Kidney

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Kidney transitional cell hyperplasia Kidney diethylhexylphthalate (DEHP)

0 - 20

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Kidney transitional cell papilloma Kidney

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Kidney transitional cell papilloma Kidney diethylhexylphthalate (DEHP)

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte - Lymphocyte hyperplasia Thymus

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte - Lymphocyte hyperplasia Thymus benzene

13.3

20

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma Thymus

6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma Thymus cyclophosphamide (Cytoxan)

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic Leukocyte - Myelocyte (Granulocyte)

0

0 - 0.9

References: Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11   ⋅   Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte - Myelocyte (Granulocyte) leukemia - myelocytic Leukocyte - Myelocyte (Granulocyte) cyclophosphamide (Cytoxan)

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte leukemia Leukocyte

2.9

1.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte lymphoma Thymus

0 - 13.3

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5   ⋅   Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte lymphoma Thymus d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Leukocyte lymphoma Thymus urethane (ethyl carbamate)

0 - 15

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Sites of Metastasis: (Unspecified organ)
Leukocyte lymphoma Leukocyte

0 - 20

0 - 13.3

References: Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11   ⋅   Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte lymphoma Leukocyte melphalan (L-phenylalanine mustard) (L-sarcolysin)

observed

References: Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11

Leukocyte lymphoma Leukocyte benzene

6.7

20

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte lymphoma Thymus benzene

0

6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte lymphoma Leukocyte cyclophosphamide (Cytoxan)

0 - 53.3

0 - 26.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte lymphoma Thymus phenacetin

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte lymphoma Leukocyte Cyclosporin A

0 - 53.3

0 - 53.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Leukocyte lymphoma Leukocyte metaproterenol

0 - 6.7

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Liver adenoma Liver

0

0.2 - 6.7

0

References: Dass SB, Cancer Lett 1999 Aug 23;143(1):81-5   ⋅   Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Liver adenoma Liver dimethylnitrosamine (DMN)

0 - 1.1

References: Dass SB, Cancer Lett 1999 Aug 23;143(1):81-5

Liver adenoma Liver 6-nitrochrysene (6-NC)

0 - 20

References: Dass SB, Cancer Lett 1999 Aug 23;143(1):81-5

Liver adenoma Liver 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

5.9 - 13.3

References: Dass SB, Cancer Lett 1999 Aug 23;143(1):81-5

Liver adenoma Liver chloroform

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Liver carcinoma Liver

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Liver carcinoma Liver chloroform

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Liver hepatocellular carcinoma Liver

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Liver hepatocellular carcinoma Liver d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Liver hepatocellular carcinoma Liver urethane (ethyl carbamate)

0 - 20

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Liver hyperplasia - oval cell Liver urethane (ethyl carbamate)

0 - 10

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Liver hyperplasia - oval cell Liver d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Liver hyperplasia - oval cell Liver

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Liver preneoplastic lesion Liver diethylnitrosamine (DEN)

observed

References: Finnberg N, Cancer Lett 2004 Apr 30;207(2):149-55

Liver tumor Liver

0

6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Liver tumor Liver chloroform

0 - 13.3

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Lung adenoma Lung

0.5 - 6.7

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5   ⋅   Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11   ⋅   Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Lung adenoma Lung urethane (ethyl carbamate)

0 - 25

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Lung adenoma Lung d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Lung adenoma Lung Cyclosporin A

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Lung adenoma Lung chloroform

0 - 6.7

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Lung hyperplasia Lung

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Lung hyperplasia Lung chloroform

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Mesodermal cell/mesoblast sarcoma Subcutis

0 - 13.3

0 - 6.7

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5   ⋅   Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11   ⋅   Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Mesodermal cell/mesoblast sarcoma Subcutis d-limonene

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Mesodermal cell/mesoblast sarcoma Subcutis urethane (ethyl carbamate)

0 - 5

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Mesodermal cell/mesoblast sarcoma CNS - Meninges

0.2 - 0.9

0

References: Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11   ⋅   Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Mesodermal cell/mesoblast sarcoma Subcutis melphalan (L-phenylalanine mustard) (L-sarcolysin)

observed

References: Mahler JF, Toxicol Pathol 1998 Jul-Aug;26(4):501-11

Sites of Metastasis: Abdominal wall , Peritoneal cavity
Mesodermal cell/mesoblast sarcoma Prostate gland

0.2

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Mesodermal cell/mesoblast sarcoma Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Mesodermal cell/mesoblast sarcoma Urinary bladder p-cresidine

0

6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Mesodermal cell/mesoblast sarcoma Subcutis benzene

0 - 6.7

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Mesodermal cell/mesoblast sarcoma Subcutis cyclophosphamide (Cytoxan)

0 - 13.3

0 - 13.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Mesodermal cell/mesoblast sarcoma Subcutis phenacetin

6.7 - 26.7

6.7 - 13.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Muscle - Smooth leiomyosarcoma Prostate gland

0.2

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Muscle - Striated - Skeletal rhabdomyosarcoma Lung

0.2

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Muscle - Striated - Skeletal rhabdomyosarcoma Muscle - Striated - Skeletal

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Muscle - Striated - Skeletal rhabdomyosarcoma Muscle - Striated - Skeletal metaproterenol

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Neuroblast neuroblastoma - olfactory Nose - Nasal cavity

0 - 0.2

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Neuroblast neuroblastoma - olfactory Nose - Nasal cavity Cyclosporin A

0 - 6.7

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Oral cavity squamous cell carcinoma Oral cavity

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Oral cavity squamous cell carcinoma Oral cavity benzene

0

6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pancreas carcinoma Pancreas

0

0.2

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars distalis adenoma Pituitary gland - Pars distalis

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars distalis adenoma Pituitary gland - Pars distalis diethylstilbestrol (DES)

13.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars distalis hyperplasia Pituitary gland - Pars distalis

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars distalis hyperplasia Pituitary gland - Pars distalis 17beta-estradiol (E2)

0 - 80

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars distalis hyperplasia - diffuse Pituitary gland - Pars distalis

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars distalis hyperplasia - diffuse Pituitary gland - Pars distalis diethylstilbestrol (DES)

93.3 - 100

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars distalis hyperplasia - nodular Pituitary gland - Pars distalis

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars distalis hyperplasia - nodular Pituitary gland - Pars distalis diethylstilbestrol (DES)

33.3 - 53.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars intermedia adenoma Pituitary gland - Pars intermedia

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars intermedia adenoma Pituitary gland - Pars intermedia diethylstilbestrol (DES)

6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars intermedia hyperplasia - diffuse Pituitary gland - Pars intermedia

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland - Pars intermedia hyperplasia - diffuse Pituitary gland - Pars intermedia diethylstilbestrol (DES)

93.3 - 100

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland adenoma Pituitary gland

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland adenoma Pituitary gland 17beta-estradiol (E2)

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland hyperplasia - focal Pituitary gland

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Pituitary gland hyperplasia - focal Pituitary gland 17beta-estradiol (E2)

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Prostate gland adenoma Prostate gland

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Prostate gland adenoma Prostate gland urethane (ethyl carbamate)

0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Prostate gland adenoma Prostate gland d-limonene

5

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Prostate gland hyperplasia - focal Prostate gland

20

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

Stomach - Glandular hyperplasia Stomach - Glandular ampicillin

observed

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Testis - Leydig cell (Interstitial cell) hyperplasia Testis - Leydig cell (Interstitial cell)

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Testis - Leydig cell (Interstitial cell) hyperplasia Testis - Leydig cell (Interstitial cell) diethylstilbestrol (DES)

26.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Testis - Leydig cell (Interstitial cell) tumor Testis - Leydig cell (Interstitial cell)

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Testis - Leydig cell (Interstitial cell) tumor Testis - Leydig cell (Interstitial cell) diethylstilbestrol (DES)

0 - 13.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Thymus hyperplasia - atypical Thymus

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Thymus hyperplasia - atypical Thymus benzene

0

26.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Thyroid gland - Follicular cell hyperplasia Thyroid gland - Follicular cell sulfamethoxazole (SMX)

observed

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Ureter hyperplasia Ureter

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Ureter hyperplasia Ureter diethylhexylphthalate (DEHP)

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder atypia Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder atypia Urinary bladder p-cresidine

33.3

40

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder dysplasia Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder dysplasia Urinary bladder p-cresidine

6.7

0 - 46.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder hyperplasia Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder hyperplasia Urinary bladder p-cresidine

73.3 - 100

100

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder metaplasia - squamous Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder metaplasia - squamous Urinary bladder p-cresidine

26.7

53.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder neoplasm Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder neoplasm Urinary bladder p-cresidine

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder papilloma Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder papilloma Urinary bladder p-cresidine

13.3

26.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder squamous cell carcinoma Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder squamous cell carcinoma Urinary bladder p-cresidine

13.3

33.3

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder transitional cell carcinoma Urinary bladder

0

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder transitional cell carcinoma Urinary bladder p-cresidine

6.7 - 73.3

20 - 66.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Urinary bladder tumor Urinary bladder p-cresidine

60

86.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Uterus - Endometrium - Stroma polyp Uterus - Endometrium - Stroma

0

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

Uterus - Endometrium - Stroma polyp Uterus - Endometrium - Stroma cyclophosphamide (Cytoxan)

0 - 6.7

References: Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

(Unspecified organ) tumor (Unspecified organ)

6.0 - 11.3

0 - 8.0

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5   ⋅   Storer RD, Toxicol Pathol 2001;29 Suppl():30-50

(Unspecified organ) tumor (Unspecified organ) urethane (ethyl carbamate)

0 - 100

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5

(Unspecified organ) tumor (Unspecified organ) d-limonene

5

References: Carmichael NG, Environ Health Perspect 2000 Jan;108(1):61-5